NCT01545791View on ClinicalTrials.gov

Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes

CompletedOBSERVATIONAL
Enrollment

1,037

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DRUG

insulin detemir

Administered once or twice daily depending on patients' needs. Dose adjusted for each patient at the discretion of their treating physician

Trial Locations (2)

DUBLIN 15

Novo Nordisk Investigational Site, Dublin

W12 OHS

Novo Nordisk Investigational Site, London

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01545791 - Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes | Biotech Hunter | Biotech Hunter